Point of Care Connectivity Solutions Market Report 2025

The point of care connectivity solutions market size has grown strongly in recent years. It will grow from $1.21 billion in 2024 to $1.33 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing demand for real-time patient monitoring, rise in chronic diseases and aging population, rising adoption of telemedicine and remote healthcare, growing need for healthcare cost reduction, increasing regulatory requirements for patient data management.

The point of care connectivity solutions market size is expected to see rapid growth in the next few years. It will grow to $1.94 billion in 2029 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to increasing integration of artificial intelligence in healthcare, rise in the number of outpatient and homecare settings, rising demand for personalized healthcare solutions, increasing investments in healthcare IT infrastructure, rising adoption of mobile health applications and wearables. Major trends in the forecast period include advanced data analytics for real-time decision making, advancement in wireless communication technologies, innovation in cloud-based healthcare solutions, and integration of IoT devices for improved patient monitoring, integration of electronic health records with point of care systems.

The forecast of 10% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. rural hospitals by driving up the cost of interoperable diagnostic data hubs and wireless vital sign monitors sourced from South Korea and the Netherlands, exacerbating health IT infrastructure costs and increasing telehealth service delays. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of diabetes is expected to drive substantial growth in the point-of-care (POC) connectivity solutions market. Diabetes refers to a group of diseases that affect how the body processes blood sugar (glucose), often leading to high blood sugar levels. The increasing prevalence of diabetes is largely due to factors such as excess body fat, which causes insulin resistance, making it harder for the body to regulate blood sugar levels effectively. Point-of-care connectivity solutions play a critical role in managing diabetes by enabling real-time monitoring of patients' health, making it easier for doctors to intervene quickly and for patients to stay on top of their condition. For example, in November 2023, the American Diabetes Association reported that in 2022, approximately 25.5 million people in the U.S. were diagnosed with diabetes, which accounted for 7.6% of the total population. As a result, the rising prevalence of diabetes is driving the growth of the point-of-care connectivity solutions market.

Companies in the point-of-care connectivity solutions market are focusing on advancing digital connectivity solutions to improve data integration, clinical workflows, and real-time decision-making at the point of care. Digital connectivity in POC refers to technology that links diagnostic devices, electronic health records (EHRs), and healthcare systems to facilitate real-time data sharing, integration, and management at the point of care. For example, in May 2022, EKF Diagnostics, a UK-based diagnostics and biotechnology company, launched a middleware connectivity solution for POC analyzers and data management. This flexible software allows for real-time remote management of patient test results, QC data, and analyzer configurations across multiple devices, seamlessly integrating with hospital IT systems, thereby enhancing functionality in hospitals, clinics, and laboratories.

In July 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, acquired LumiraDx, a UK-based medical technology manufacturer, for an undisclosed amount. This acquisition enables Roche to strengthen its position in the point-of-care diagnostics market by integrating LumiraDx's advanced diagnostic platform and digital connectivity solutions into its portfolio. The move enhances Roche’s ability to provide rapid testing capabilities, making it a key player in the growing market for point-of-care connectivity solutions.

Major players in the point of care connectivity solutions market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Honeywell International Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., TE Connectivity Ltd., Quest Diagnostics Incorporated, VWR International LLC, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Bio-Rad Laboratories Inc., WerfenLife S.A. (Werfen), Radiometer Medical ApS, Nova Biomedical Corporation, LumiraDx Limited, EKF Diagnostics Holdings plc, Abbott Laboratories, Orchard Software Corporation, Citizen Care Health Solutions Inc.

North America was the largest region in the point-of-care connectivity solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point-of-care connectivity solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the point-of-care connectivity solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care connectivity solutions market consists of revenues earned by entities by providing services such as real-time data monitoring and transmission, remote patient monitoring, and cloud-based connectivity. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care connectivity solutions market includes sales of monitoring devices, wireless patient monitoring systems, integration middleware. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment - many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The point of care connecting solutions market research report is one of a series of new reports that provides point of care connecting solutions market statistics, including point of care connecting solutions industry global market size, regional shares, competitors with a point of care connecting solutions market share, detailed point of care connecting solutions market segments, market trends and opportunities, and any further data you may need to thrive in the point of care connecting solutions industry. This point of care connecting solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Point-of-care (POC) connectivity solutions are technologies and systems that enable the seamless transfer of health data from POC diagnostic devices to healthcare professionals, typically integrating this data into electronic health records (EHRs). These solutions allow for real-time access to patient information, enhancing clinical decision-making and improving patient outcomes.

The primary types of point-of-care connectivity solutions are software and services. Software refers to the applications and platforms that enable medical devices and healthcare information systems to integrate and communicate with each other. These solutions are used in various applications, such as glucose monitoring, coagulation monitoring, electrolyte and blood gas analysis, infectious disease diagnostics, cardio-metabolic monitoring, and others. They are utilized by a range of end users, including hospitals and clinics, diagnostic and specialty centers, and other healthcare facilities.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.